Europe’s drug regulator said on Wednesday it had assessed nine cases of an auto-immune blood condition following vaccination with Moderna Inc’s
COVID-19 shot, but no "clear causal relationship" could be established between the two.
The European Medicines Agency (EMA) said its safety committee would continue to monitor for cases of immune thrombocytopenia, an auto-immune condition with low blood platelet levels that can lead to bruising and bleeding, with Moderna’s vaccine, Spikevax.
For the latest headlines, follow our Google News channel online or via the app.
Read more: Will add warning about rare heart inflammation to Pfizer, Moderna vaccines, says FDA
Also Read
-
Saudi Arabia approves Moderna COVID-19 vaccine for use
-
UAE approves Moderna’s COVID-19 vaccine for emergency use
-
Pfizer, Moderna vaccines could protect against COVID-19 for years: Study
-
More Moderna COVID-19 shots sent to Taiwan to bolster vaccine rollout
-
Will add warning about rare heart inflammation to Pfizer, Moderna vaccines, says FDA
-
Moderna seeks EU, Canada approval to expand use of COVID-19 vaccine in teens
-
Moderna says its COVID-19 shot works in kids as young as 12